Room 202
Purpose: Capital equipment and maintenance costs are major causes for limited RT access in low- and middle-income countries. We are developing a novel cobalt-compensator based IMRT device that can provide cost-effective and reliable RT in limited-resource settings. The goal of this work is to investigate the quality of treatment plans.
Methods: Cobalt beam data from Monte Carlo(MC) simulation was used for beam-commissioning within the treatment planning system (TPS) and for plan validation. Thirty clinical head & neck and cervical cancer cases were planned and compared with a 6 MV linac using IMRT. Patient-specific compensators were created within the TPS as regions-of-interests.
Results: Dose coverage of targets and OAR sparing was comparable to clinical plans using a 6MV linac. OAR sparing was similar to clinical plans (e.g. parotid gland mean dose 2600 cGy). PTV objectives were achieved in all 30 plans with PTV V95% > 95%. Dmax < 45 Gy for spinal cord was achieved in 25 cases. Initial data on cervical cases suggests bowel sparing similar to clinical plans, with V15 < 195 cc. The average field-by-field gamma pass rate was 93.7% (2%/2mm). Estimated treatment times using the Co-60 compensator device was similar to the times from the clinical plans with an average radiation delivery time of 1 min 27 seconds vs 1 min 2 seconds for the clinical system.
Conclusion: This system is the first of its kind to allow for IMRT with a Co-60 device. Plan quality criteria were met while maintaining short treatment times which may offer a sustainable and cost-effective option for IMRT on the global scale.
Funding Support, Disclosures, and Conflict of Interest: This work was supported by the National Cancer Institute of the National Institutes of Health under Award Number 5UH3 CA211310-04
Co-60, Compensators, Intensity Modulation
TH- External Beam- Photons: Development (new technology and techniques)